Mini-review: The therapeutic role of cannabinoids in neuroHIV.

Mini-review: The therapeutic role of cannabinoids in neuroHIV.
复制标题

迷你评论:大麻素在神经HIV中的治疗作用。

DOI:
10.1016/j.neulet.2021.135717
复制
发表时间:
2021-04-17
影响因子:
2.5
通讯作者:
Fitting S
Fitting S
中科院分区:
医学4区
文献类型:
--
作者:
Yadav-Samudrala BJ;Fitting S

文献摘要

参考文献

相似文献

在联合抗逆转录病毒治疗(cART)时代,人类免疫缺陷病毒1型(HIV-1)被认为是一种慢性疾病,具有特异性靶向大脑的炎症成分,并导致HIV-1相关神经认知障碍(HAND)的高患病率。内源性大麻素(eCB)系统由于大麻素的潜在抗炎和神经保护特性(包括其在HIV-1神经发病机制中的潜在治疗用途)而作为治疗神经退行性疾病的靶点引起了人们的兴趣。在这篇综述中,我们总结了什么是目前已知的eCB系统的结构和功能的变化条件下的手。随后将总结当前临床和临床前研究结果对大麻使用和大麻素在HIV-1感染背景下的影响,特别关注病毒载量,认知,炎症和神经保护。最后,我们提出了一些潜在的未来方向,以更好地了解eCB系统的参与以及大麻使用和大麻素在neuroHIV中的作用。
In the era of combined antiretroviral therapy (cART), human immunodeficiency virus type 1 (HIV-1) is considered a chronic disease with an inflammatory component that specifically targets the brain and causes a high prevalence of HIV-1-associated neurocognitive disorders (HAND). The endocannabinoid (eCB) system has attracted interest as a target for treatment of neurodegenerative disorders, due to the potential anti-inflammatory and neuroprotective properties of cannabinoids, including its potential therapeutic use in HIV-1 neuropathogenesis. In this review, we summarize what is currently known about the structural and functional changes of the eCB system under conditions of HAND. This will be followed by summarizing the current clinical and preclinical findings on the effects of cannabis use and cannabinoids in the context of HIV-1 infection, with specifically focusing on viral load, cognition, inflammation, and neuroprotection. Lastly, we present some potential future directions to better understand the involvement of the eCB system and the role that cannabis use and cannabinoids play in neuroHIV.
DOI: 10.4103/1673-5374.191208
发表时间: 2016-09
影响因子: 6.1
作者:
Concannon RM;Dowd E
通讯作者: Dowd E
DOI: 10.1111/bph.12478
发表时间: 2014-01-01
影响因子: 7.3
作者:
Avraham, Hava Karsenty;Jiang, Shuxian;Avraham, Shalom
通讯作者: Avraham, Shalom
DOI: 10.7326/0003-4819-139-4-200308190-00008
发表时间: 2003-08-19
影响因子: 39.2
作者:
Abrams, DI;Hilton, JF;Schambelan, M
通讯作者: Schambelan, M
DOI: 10.1212/01.wnl.0000253187.66183.9c
发表时间: 2007-02-13
期刊: NEUROLOGY
影响因子: 9.9
作者:
Abrams, D. I.;Jay, C. A.;Petersen, K. L.
通讯作者: Petersen, K. L.
DOI: 10.1126/science.277.5322.112
发表时间: 1997-07-04
期刊: SCIENCE
影响因子: 56.9
作者:
Autran, B;Carcelain, G;Leibowitch, J
通讯作者: Leibowitch, J